[1]刘晓蓉 朱德发.糖尿病下肢动脉病变的诊断与治疗[J].国际内分泌代谢杂志,2015,(05):327-331.[doi:DOI:10.3760/cma.j.issn.1673-4157.2015.05.010]
　Liu Xiaorong*,Zhu Defa..Diagnosis and treatment of lower extremity arterial disease in diabetes mellitus[J].International Journal of Endocrinology and Metabolism,2015,(05):327-331.[doi:DOI:10.3760/cma.j.issn.1673-4157.2015.05.010]
点击复制

糖尿病下肢动脉病变的诊断与治疗()
分享到：

《国际内分泌代谢杂志》[ISSN:1673-4157/CN:12-1383/R]

卷:
期数:
2015年05期
页码:
327-331
栏目:
临床研究
出版日期:
2015-09-20

文章信息/Info

Title:
Diagnosis and treatment of lower extremity arterial disease in diabetes mellitus
作者:
刘晓蓉 朱德发
232001 淮南,安徽省淮南朝阳医院内分泌科(刘晓蓉); 230022 合肥,安徽医科大学第一附属医院老年内分泌科(朱德发)
Author(s):
Liu Xiaorong*; Zhu Defa.
*Department of Endocrinology,The Anhui Red Cross Chaoyang Hospital, Huainan 232001,China
关键词:
糖尿病;  下肢动脉病变;  诊断;  治疗
Keywords:
Diabetes mellitus;  Lower extremity arterial disease;  Diagnosis;  Therapy
DOI:
DOI:10.3760/cma.j.issn.1673-4157.2015.05.010
摘要:
下肢动脉粥样硬化性病变(LEAD)是糖尿病的常见慢性并发症之一,最常累及下肢动脉的远端血管。踝肱指数、彩色多普勒超声等是糖尿病LEAD简单、可靠、常用的筛查方法,可以达到早期诊断的效果。基础治疗、运动治疗、扩血管药物的应用等早期治疗能有效缓解症状,降低糖尿病足和截肢的风险。对于有明显的临床症状及体征的糖尿病LEAD患者还需借助CT血管成像或磁共振血管成像及数字减影血管造影检查,以进一步评价下肢血管病变的严重程度及病变部位,在基础治疗的前提下,联合血管重建及干细胞移植。
Abstract:
Lower extremity atherosclerotic disease(LEAD),which most frequently affects the distal blood vessels of lower limb,is one of the common chronic complications in patients with diabetes mellitus. Ankle-brachial index(ABI)and color doppler ultrasound are common, simple and reliable methods for screening LEAD in patients with diabetes mellitus, and can achieve the effects of early diagnosis of LEAD. The early treatments, including basic, exercise and vasodilators therapy can effectively relieve symptoms, reduce the risk of diabetic foot and amputation. For patients with diabetes mellitus and obvious clinical symptoms and signs of LEAD, it can define the area of vascular lesions and severity through computed tomography angiography, magnetic resonance angiography or distal subtraction angiography. On the premise of basic treatment,the patients with diabetes mellitus and LEAD get more benefit through revsculrization or stem cell transplantation.

参考文献/References:

[1] Wang L, DU F Mao H,et al. Prevalence and related risk factors of peripheral arterial disease in elderly patients with type 2 diabetes in Wuhan,Central China[J]. Chin Med J(Engl),2011,124(24):4264-4268. [/br][2] 2011 WRITING GROUP MEMBERS; 2005 WRITING COMMITTEE MEMBERS; ACCF/AHA TASK FORCE MEMBERS.2011 ACCF/AHA Focused Update of the Guideline for the Management of patients with peripheral artery disease(Updating the 2005 Guideline): a report of the American College of Cardiology Foundation/American Heart Association Task Force on practice guidelines[J]. Circulation, 2011,124(18):2020-2045. [/br][3] Xu D, Li J,Zou J, et al. Sensitivity and specificity of the ankle-brachial index to diagnose peripheral artery disease: a structured review[J]. Vasc Med, 2010, 15(5): 361-369. [/br][4] 王莉, 杨彩哲, 王良宸, 等.趾臂指数诊断早期糖尿病下肢血管病变的价值研究[J]. 中国全科医学, 2014,17:1950-1954. [/br][5] Hoe J, Koh WP,Jin A, et al. Predictors of decrcase in ankle-brachial index among patients with diabetes mellitus[J]. Diabet Med, 2012,29(9):e304-e307. [/br][6] 柴萌,张海涛,黄丛春,等. 无创检查在糖尿病足下肢血管病变中的诊断价值与DSA对照研究[J].医学影像学杂志,2008,18(3):300-303. [/br][7] 丁胜,赵湜,王红祥,等.经皮氧分压检测诊断2型糖尿病患者周围血管病变的临床价值[J]. 山东医药,2009,49(37):33-34. [/br][8] 中华医学会糖尿病学分会.2型糖尿病患者合并下肢动脉病变的筛查及管理规范(2012年)[J].中华糖尿病杂志,2013,5(2):82-88. [/br][9] Röhrl B, Kunz RP, Oberholzer K,et al.Gadofosveset-enhanced MR angiography of the pedal arteries in patients with diabetes mellitus and comparison with selective intraarterial DSA[J].Eur Radiol, 2009,19(12):2993-3001. [/br][10] 郭红敏, 戚玉龙, 刘阳, 等. 非增强磁共振血管成像对糖尿病下肢动脉狭窄的诊断价值[J]. 中国医学影像学杂志, 2013, 21(8): 561-565. [/br][11] 中华医学会老年医学分会,中华医学会外科学分会血管外科专业组,中华老年医学杂志编辑委员会.老年人四肢动脉粥样硬化性疾病诊治中国专家建议(2012)[J].中华老年医学杂志,2013,32(2):121-131. [/br][12] 刘春斌,王立民,黄松. 中国居民2型糖尿病下肢血管病变危险因素的Meta分析研究[J]. 中国全科医学,2010,13(31):3516-3518,3522. [/br][13] Collins TC,Lunos S,Carlson T,et al. Effects of a home-based walking intervention on mobility and quality of life in people with diabetes and peripheral arterial disease:a randomized controlled trial[J].Diabetes Care,2011,34(10):2174-2179. [/br][14] 王爱红,姬秋和,徐向前,等. 前列地尔注射液治疗2型糖尿病并发下肢动脉闭塞症的临床研究——多中心、随机、双盲、阳性药平行对照研究[J].中华内分泌代谢杂志,2009,25(6):608-609. [/br][15] Matsumoto T, Iwasa K, Kyuragi R, et al. The efficacy of oral beraprost sodium,a prostaglandin I2 analogue,for treating intermittent claudication in patients with arteriosclerosis obliterans[J].Int Angiol,2010,29(2 Suppl):49-54. [/br][16] Topal AE, Eren MN.Comparison of effects of iloprost and pentoxiphylline on walking capacity and skin oxygenation in diabetic patients with peripheral artery disease[J].Atr J Pharm Pharmaco, 2012,6(5):294-299. [/br][17] De Sanctis MT, Cesarone MR, Belcaro G, et al.Treatment of intermittent claudication with pentoxifylline: a 12-month, randomized trial-walking distance and microcirculation[J]. Angiology, 2002,53(Suppl 1):S7-S12. [/br][18] 任师颜,王非,钱松屹,等. 盐酸沙格雷酯治疗下肢动脉硬化闭塞症的疗效观察[J].中日友好医院学报,2012,26(3):142-144. [/br][19] 吴心池,施广德,黄文龙,等. 沙格雷酯与西洛他唑治疗2型糖尿病下肢血管病变的临床对照研究[J]. 中国糖尿病杂志,2010,18(8):607-610. [/br][20] 庄舜玖,景在平,李黎,等. 阿加曲班注射液不同给药方法治疗慢性动脉闭塞症的疗效比较 [J]. 上海医学,2005,28(5):390-392. [/br][21] Kameda K, Kikkawa Y, Hirano M,et al. Combined argatroban and anti-oxidative agents prevents increased vascular contractility to thrombin and other ligands after subarachnoid haemorrhage[J].Br J Pharmacol, 2012,165(1):106-119. [/br][22] 林彬,杨红,纪艳超,等. 阿加曲班与葛根素联合治疗糖尿病下肢动脉硬化闭塞症的临床研究[J]. 现代生物医学进展,2012,12(19):3678-3680. [/br][23] Jude EB,Eleftheriadou I,Tentolouris N.Peripheral arterial disease in diabetes-a review[J].Diabet Med, 2010,27(1):4-14. [/br][24] Xiao L,Huang DS,Tong JJ,et al.Efficacy of endoluminal interventional therapy in diabetic peripheral arterial occlusive disease:a retrospective trial[J]. Cardiovasc Diabetol, 2012,11:17. [/br][25] 钱结胜,王皓帆,徐长谋. 经皮血管腔内成形术结合局部小剂量持续灌注溶栓治疗糖尿病膝下动脉病变[J].中华放射学杂志,2015,49(1):11-15. [/br][26] Hinchliffe RJ,Andros G,Apelqvist J,et al.A systematic review of the effectiveness of revascularization of the ulcerated foot in patients with diabetes and peripheral arterial disease[J].Diabetes Metab Res Rev,2012,28(Suppl 1):179-217. [/br][27] Kirana S,Stratmann B,Prante C,et al. Autologous stem cell therapy in the treatment of limb ischaemia induced chronic tissue ulcers of diabetic foot patients [J]. Int J Clin Pract,2012,66(4):384-393. [/br][28] 中华医学会糖尿病学分会.中华医学会糖尿病学分会关于干细胞移植治疗糖尿病下肢动脉病变的立场声明[J].中华糖尿病杂志,2010,2(6):404-409.

相似文献/References:

[1]郑少雄.罗格列酮和心血管风险——近期文献解读[J].国际内分泌代谢杂志,2007,(04):231.
[2]凌厉,朱本章.胰岛素类似物安全性研究进展[J].国际内分泌代谢杂志,2007,(04):234.
[3]李颖,刘东方.餐后1小时血糖升高的意义及干预[J].国际内分泌代谢杂志,2007,(04):235.
[4]崔巍,施秉银.内质网应激介导β细胞生存/死亡的研究进展[J].国际内分泌代谢杂志,2007,(04):256.
[5]杨叶虹,胡仁明.SELDI-TOF-MS技术及其在糖尿病研究中的应用[J].国际内分泌代谢杂志,2007,(04):261.
[6]高妍.针对华人糖尿病特点优化降糖方案[J].国际内分泌代谢杂志,2007,(04):269.
[7]杨志霞,郭莹辉,杨永生,等.胰岛素泵和多次皮下注射治疗糖尿病的比较[J].国际内分泌代谢杂志,2007,(04):273.
[8]周建英,马向华.胃旁路术减肥同时改善糖代谢的机制[J].国际内分泌代谢杂志,2007,(04):285.
[9]李翠柳,朱大龙.破译肠道代谢信息,驱动治疗革新[J].国际内分泌代谢杂志,2014,(06):383.[doi:10.3760/cma.j.issn.1673-4157.2014.06.006]
　Li Cuiliu*,Zhu Dalong..Deciphering metabolic messages from the gut drives therapeutic innovation[J].International Journal of Endocrinology and Metabolism,2014,(05):383.[doi:10.3760/cma.j.issn.1673-4157.2014.06.006]
[10]袁捷 姜云生 杜彦丽 王肃.1型糖尿病对小鼠早孕时期子宫肌层结构和细胞增殖的影响[J].国际内分泌代谢杂志,2015,(01):6.[doi:10.3760/cma.j.issn.1673-4157.2015.01.002]
　Yuan JieJiang YunshengDu YanliWang Su.Effects of type 1 diabetes on the muscularis structure and cell proliferation of uterine in mice during early pregnancy[J].International Journal of Endocrinology and Metabolism,2015,(05):6.[doi:10.3760/cma.j.issn.1673-4157.2015.01.002]

备注/Memo

备注/Memo:
基金项目:国家自然科学基金资助项目(81272152) 作者单位:232001 淮南,安徽省淮南朝阳医院内分泌科(刘晓蓉); 230022 合肥,安徽医科大学第一附属医院老年内分泌科(朱德发) 通信作者:朱德发,Email:zdfa0168@sina.com
更新日期/Last Update: 2015-09-20